Article Details
Retrieved on: 2025-01-30 18:32:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes the MHRA's updates to the Innovative Licensing and Access Pathway (ILAP), enhancing collaboration between regulatory and health bodies like the NHS, using business intelligence to streamline drug approval and access. Tags like MHRA and NHS are relevant as significant actors in this process.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here